Profile for Spain Patent: 2903419
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Spain Patent: 2903419
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| 10,493,028 | Mar 13, 2035 | Azurity | FIRVANQ KIT | vancomycin hydrochloride |
| 10,688,046 | Mar 13, 2035 | Azurity | FIRVANQ KIT | vancomycin hydrochloride |
| 10,959,946 | Mar 13, 2035 | Azurity | FIRVANQ KIT | vancomycin hydrochloride |
| 10,959,947 | Mar 13, 2035 | Azurity | FIRVANQ KIT | vancomycin hydrochloride |
| 10,959,948 | Mar 13, 2035 | Azurity | FIRVANQ KIT | vancomycin hydrochloride |
| 10,959,949 | Mar 13, 2035 | Azurity | FIRVANQ KIT | vancomycin hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
